Stroke in Black Americans

Current Cardiology Reports

Volumn 7, Issue 1, 2005, Pages 29-33

  Ruland, Sean ^a   Gorelick, Philip B ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; CHOLESTEROL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN S; TICLOPIDINE; WARFARIN;

AFRICAN AMERICAN; AGE DISTRIBUTION; ALCOHOL ABUSE; BLOOD PRESSURE REGULATION; BRAIN ANGIOGRAPHY; BRAIN HEMORRHAGE; CAROTID ENDARTERECTOMY; CEREBROVASCULAR ACCIDENT; CIGARETTE SMOKING; CLINICAL TRIAL; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; EXCHANGE BLOOD TRANSFUSION; FIBRINOLYTIC THERAPY; GLASGOW OUTCOME SCALE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INCIDENCE; MEDICAL RESEARCH; MORTALITY; OBESITY; PATIENT ATTITUDE; PATIENT CARE; PATIENT EDUCATION; PATIENT PARTICIPATION; PREVALENCE; RACE DIFFERENCE; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; RISK REDUCTION; SICKLE CELL ANEMIA; SIDE EFFECT; SOCIAL STATUS; SUBARACHNOID HEMORRHAGE; SYSTEMATIC REVIEW; TRUST;

EID: 13544268707     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-005-0007-5     Document Type: Review

References (40)

1. Gillum RF: Secular trends in stroke mortality in African Americans: the role of urbanization, diabetes and obesity. Neuroepidemiology 1997, 16:180-184.
2. American Heart Association: Heart Disease and Stroke Statistics - 2004 Update. Dallas: American Heart Association; 2003.
3. Gorelick PB: Cerebrovascular disease in African Americans. Stroke 1998, 29:2656-2664.
4. Kissela B, Schneider A, Kleindorfer D, et al.: Stroke in a biracial population: the excess burden of stroke among Blacks. Stroke 2004, 35:426-431.
5. Gorelick PB, Richardson D, Kelly M, et al.: Aspirin and ticlopidine for prevention of recurrent stroke in black patients: a randomized trial. JAMA 2003, 289:2947-2957.
6. Hassaballa H, Gorelick PB, West CP, et al.: Ischemic stroke outcome: racial differences in the Trial of Danaparoid in Acute Stroke (TOAST). Neurology 2001, 57:691-697.
7. Kizer JR, Silvestry FE, Kimmel SE, et al.: Racial differences in the prevalence of cardiac sources of embolism in subjects with unexplained stroke or transient ischemic attack evaluated by transesophageal echocardiography. Am J Cardiol 2002, 90: 95-400.
8. Prengler M, Pavlakis SG, Prohovnik I, Adams RJ: Sickle cell disease: the neurological complications. Ann Neurol 2002, 51:543-552.
9. Adam RJ, Nichols FT, McKie V, et al.: Cerebral infarction in sickle cell anemia: mechanism based on CT and MRI. Neurology 1988, 38:1012-1017.
10. Adams R, McKie V, Nichols F, et al.: The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med 1992, 326:605-610.
11. Adams RJ, McKie VC, Hsu L, et al.: Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial doppler ultrasonography. N Engl J med 1998, 339:5-11.
12. Sloan MA, Alexandrov AV, Tegeler CH, et al.: Assessment: transcranial Doppler ultrasonography: report of the therepeutics and technology assessment subcommittee of the American Academy of Neurology. Neurology 2004, 9:1468-1481.
13. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995, 333:1581-1587.
14. Johnston SC, Fung LH, Gillum LA, et al.: Utilization of intravenous tissue-type plasminogen activator for ischemic stroke at academic medical centers: the influence of ethnicity. Stroke 2001, 31:1061-1068.
15. Christian JB, Lapane KL, Toppa RS: Racial disparities in receipt of secondary stroke prevention agents among US nursing home residents. Stroke 2003, 34:2693-2697.
16. Oddone EZ, Horner RD, Monger ME, Matchar DB: Racial variations in the rates of carotid angiography and endarterectomy in patients with stroke and transient ischemic attack. Arch Intern Med 1993, 153:2781-2786.
17. Oddone EZ, Horner RD, Sloane R, et al.: Race, presenting signs and symptoms, use of carotid artery imaging, and appropriateness of carotid endarterectomy. Stroke 1999, 30: 350-1356.
18. Oddone EZ, Horner RD, Johnston DC, et al.: Carotid endarterectomy and race: do clinical indications and patient preferences account for differences? Stroke 2002, 33:2936-2943.
19. Goldstein LB, Matchar DB, Hoff-Lindquist J, et al.: Veterans Administration Acute Stroke (VASt) Study: lack of race/ethnic-based differences in utilization of stroke-related procedures or services. Stroke 2003, 34:999-1004.
20. Harris Y, Gorelick PB, Samuels P, Bempong I: Why African Americans may not be participating in clinical trials. J Natl Med Assoc 1996, 88:630-634.
21. Gorelick PB, Harris Y, Burnett B, Bonecutter FJ: The recruitment triangle: reasons why African Americans enroll, refuse to enroll, or voluntarily withdraw from a clinical trial. J Natl Med Assoc 1998, 90:141-145.
22. Lynch GF, Gorelick PB, Raman R, Leurgans S: A pilot survey of African American physician perceptions about clinical trials. J Natl Med Assoc 2001, 93:8S-13S.
23. Weisberg LA, for the Ticlopidine Aspirin Stroke Study Group: The efficacy and safety of ticlopidine and aspirin in non-whites: analysis of a patient subgroup from the Ticlopidine Aspirin Stroke Study. Neurology 1993, 43:27-31.
24. Harris MI, Hadden WC, Knowler WC, et al.: Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in u.s. population aged 20-74 yr. Diabetes 1987, 36:523-534.
25. Burt VL, Whelton P, Rocella EJ, et al.: Prevalence of hypertension in the U.S. adult population: results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995, 25:305-313.
26. Qureshi AI, Suri MFK, Guterman LR, et al.: Ineffective secondary prevention in survivors of cardiovascular events in the U.S. population: report from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2001, 161:1621-1628.
27. Sacco RL, Kargman DE, Samanillo MC: Race-ethnic differences in stroke risk factors among hospitalized patients with cerebral infarction: the Northern Manhattan Stroke Study. Neurology 1995, 45:659-663.
28. Lynch GF, Leurgans S, Raman R, et al.: A comparison of stroke risk factors in patients enrolled in stroke prevention trials. J Natl Med Assoc 2001, 93:79-86.
29. Worrall BB, Johnston KC, Kongable G, et al.: Stroke risk factor profiles in African American women: an interim report from the African-American Antiplatelet Stroke Prevention Study. Stroke 2002, 33:913-919.
30. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among U.S. adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 2002, 287:356-359.
31. Winkleby MA, Robinson TN, Sundquist J, Kraemer HC: Ethnic variation in cardiovascular disease risk factors among children and young adults: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. JAMA 1999, 281:1006-1013.
32. Ruland S, Raman R, Chaturvedi S, et al.: Awareness, treatment, and control of vascular risk factors in African Americans with stroke. Neurology 2003, 60:64-68.
33. Burt VL, Cutler JA, Higgins M, et al.: Trends in the prevalence, awareness, treatment, and control of hypertension in the adult U.S. population: data from the Health Examination Surveys, 1960-1991. Hypertension 1995, 26:60-69.
34. Bone LR, Hill MN, Stallings R, et al.: Community health survey in an urban African-American neighborhood: distribution and correlates of elevated blood pressure. Ethnic Dis 2000, 10: 7-95.
35. Freeman V, Rotimi C, Cooper R: Hypertension prevalence, awareness, treatment and control among African Americans in the 1990s: estimates from the Maywood Cardiovascular Survey. Am J Prev Med 1996, 12:177-185.
36. Kernan WN, Viscoli CM, Brass LM, et al.: Blood pressure exceeding national guidelines among women after stroke. Stroke 2000, 31:415-419.
37. Joseph LN, Babikian VL, Allen NC, et al.: Risk factor modification in stroke prevention: the experience of a stroke clinic. Stroke 1999, 30:16-20.
38. Nieto FJ, Alonso J, Chambless LE, et al.: Population awareness and control of hypertension and hypercholesterolemia: the Atherosclerosis Risk in Communities Study. Arch Intern Med 1995, 155:677-684.
39. Chalmers J: Global impact of hypertension. Heart Dis 2000, 2:S13-S17.
40. Whittley CY, Gorelick PB, Raman R, et al.: Are there differences in risk factor profiles and frequency of CT/MRI-based infarcts among African American stroke patients with and without hypertension? J Natl Med Assoc 2003, 95:423-432.